Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 188.66M 90.46M 2023-12
Adma Biologics USD 51.35M 22.8M 2023-12
ALKERMES USD 647.71M 18.08M 2023-09
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
AstraZeneca USD 4.87B 793M 2023-09
BioCryst Pharmaceuticals USD 397.59M 251.38M 2023-09
Bristol-Myers Squibb USD 11.46B 3.95B 2023-12
Clal Biotechnology ILS 7.44M 734K 2022-12
Compugen USD 47.78M 30.71M 2023-09
Dynavax Technologies USD 150.28M 4.23M 2023-12
Eli Lilly USD 2.38B 313.7M 2023-09
Esperion Therapeutics USD 114.83M 23.64M 2023-09
GlaxoSmithKline GBP 3.18B 37M 2023-09
Grifols EUR 484.23M 39.13M 2023-09
Halozyme Therapeutics USD 118.37M 155.86M 2023-12
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
J&J USD 3.5B 497M 2023-09
Marinus Pharmaceuticals USD 140.44M 12.65M 2023-09
Merck USD 8.6B 2.94B 2023-09
Minerva Neurosciences USD 46.9M 4.89M 2023-09
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
Novavax USD 651.1M 145.19M 2023-09
Pfizer USD 3.15B 516M 2023-09
Roche Holding CHF 3.72B 1.27B 2023-06
Takeda JPY 318.05B 1.67B 2023-09
Vanda Pharmaceuticals USD 150.03M 204.14M 2023-06



Minerva Neurosciences Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.